| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | 0.2 | 3e-08 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | 0.21 | 6e-07 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | 0.19 | 1e-06 |
| mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | 0.35 | 1e-06 |
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | 0.36 | 3e-06 |
| mRNA | AT13387 | CTRPv2 | pan-cancer | AAC | -0.23 | 1e-05 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | -0.15 | 4e-05 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | 0.15 | 5e-05 |
| mRNA | SNX-2112 | CTRPv2 | pan-cancer | AAC | -0.15 | 6e-05 |
| mRNA | selumetinib:PLX-4032 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.16 | 8e-05 |